http www.abcam.com glutathione-s-transferase-mu-antibody-ab53942.html Anti-Glutathione S Transferase mu antibody [CPTC-GSTMu1-3] - BSA and Azide free (ab268190) Immunogen corresponding to Recombinant Full Length Protein corresponding to Human GSTM1. Anti-Glutathione Peroxidase 4 antibody

Sweet Potatoes: Sweet potatoes are rich in potassium, which decreases the risk of high blood pressure

Evidence Based Research This article has been researched and written based on scientific evidence and fact sheets that have then been crossed checked by our team of doctors and subject matter experts

Tolerogenic DCs have been shown to help allograft adoption through deletion of alloreactive T cells and activation of donor-specific regulatory T cells (Treg), and skewing the Th1/Th2 response (112)

~403 Da (copper complex) Form: Lyophilized powder Vial Size: 50mg in 3mL glass vial Purity: 99%+ verified by HPLC and mass spectrometry (See COAs) Research Background GHK-Cu has been investigated in research literature across several scientific contexts: Tissue biology research investigations into peptide-copper complex effects on cellular signaling pathways in tissue models Extracellular matrix research studies examining cellular responses involving collagen synthesis pathways and matrix protein regulation in cell culture systems Copper-binding peptide chemistry analytical chemistry research on GHKs selective copper binding properties and the cellular biology of copper homeostasis Cellular signaling pathway research investigations into GHK-Cus interactions with cellular receptor systems and downstream signaling cascades Gene expression research studies examining GHK-Cus effects on cellular gene expression patterns in research models Comparative peptide research analytical studies positioning GHK-Cu alongside other naturally occurring copper-binding peptides in cellular research contexts GHK-Cu is historically significant as one of the most extensively studied naturally occurring copper-binding peptides, originally identified by Pickart et al

Molecular Markers for Treatment Decisions in GI Malignancies

10.1111/j.1523-5378.2010.00768.x 113 DobsonR.GiovannoniG